Search Grant Opportunities

Drug-Free Communities (DFC) Support Program – Non-competing Continuation

ID: CDC-RFA-CE20-2004 • Type: Posted

Description

Drug-Free Communities (DFC) Support Program Non-competing Continuation

Overview

Category of Funding
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/14/20 Injury Center posted grant opportunity CDC-RFA-CE20-2004 for Drug-Free Communities (DFC) Support Program – Non-competing Continuation with funding of $125,000. The grant will be issued under grant program 93.276 Drug-Free Communities Support Program Grants. It is expected that 150 total grants will be made.

Timing

Posted Date
Feb. 14, 2020, 12:00 a.m. EST
Closing Date
June 15, 2020, 12:00 a.m. EDT Past Due
Last Updated
April 15, 2020, 12:32 p.m. EDT
Version
7
Archive Date
June 16, 2020

Eligibility

Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
This award will be a continuation of funds intended only for recipients previously awarded under the following notice of funding opportunities:• Drug-Free Communities (DFC) Support Program – Competing Continuation, SP-19-006• Drug-Free Communities (DFC) Support Program – New, SP-19-005• Drug-Free Communities Support Program – Competing Continuation, SP-18-003• Drug-Free Communities Support Program – New, SP-18-002• Drug-Free Communities (DFC) Support Program – Competing Continuation, SP-17-002 • Drug-Free Communities (DFC) Support Program – New, SP-17-001• Drug-Free Communities (DFC) Support Program, SP-16-001

Award Sizing

Ceiling
$125,000
Floor
Not Listed
Estimated Program Funding
$125,000
Estimated Number of Grants
150

Contacts

Contact
Linton C Browning Grants Management Specialist
Contact Email
Contact Phone
(770) 488-2756

Documents

Posted documents for CDC-RFA-CE20-2004

Grant Awards

Grants awarded through CDC-RFA-CE20-2004

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to CDC-RFA-CE20-2004